Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 6,883 | 2,357 | 4,651 | 7,418 | 3,573 |
| Gross Profit | 6,883 | 2,357 | 4,651 | 7,418 | 3,573 |
| Operating Expenses | 161,425 | 117,591 | 75,894 | 70,772 | 58,604 |
| Operating Income | -154,542 | -115,234 | -71,243 | -63,354 | -55,031 |
| Other Income | 13,113 | 2,909 | 505 | 2,407 | 4,153 |
| Pre-tax Income | -141,429 | -112,325 | -70,738 | -60,947 | -50,878 |
| Income Tax | N/A | N/A | -227 | -1,167 | N/A |
| Net Income Continuous | -141,429 | -112,325 | -70,511 | -59,780 | -50,878 |
| Net Income | $-141,429 | $-112,325 | $-70,511 | $-59,780 | $-50,878 |
| EPS Basic Total Ops | -2.92 | -2.40 | -1.64 | -2.02 | -3.51 |
| EPS Basic Continuous Ops | -2.92 | -2.40 | -1.64 | -2.02 | -3.51 |
| EPS Diluted Total Ops | -2.92 | -2.40 | -1.64 | -2.02 | -3.51 |
| EPS Diluted Continuous Ops | -2.92 | -2.40 | -1.64 | -2.02 | -3.51 |
| EPS Diluted Before Non-Recurring Items | -2.66 | -2.23 | -1.58 | -1.80 | -3.28 |
| EBITDA(a) | $-157,756 | $-111,494 | $-67,884 | $-42,154 | $-51,313 |